Haurwitz Rachel E. 13D and 13G filings for Caribou Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-06 4:06 pm Purchase | 2023-07-18 | 13D | Caribou Biosciences, Inc. CRBU | Haurwitz Rachel E. | 4,378,913 4.800% | 757,594 (+20.92%) | Filing |
| 2022-02-04 09:00 am Purchase | 2022-02-01 | 13D | Caribou Biosciences, Inc. CRBU | Haurwitz Rachel E. | 3,621,319 6.000% | 3,621,319 (New Position) | Filing |